Malibu Boats, Inc. (NASDAQ:MBUU) recently ticked higher on strong volume. About 0.28 million contracts were traded on 05-Dec-17 compared to daily average volume of 0.26 million shares. The first sale was made at $29.68 but later the stock became weaker, and closed with a gain of 3.79%. It was last traded at $30.7 apiece.

Malibu Boats, Inc. (MBUU): Outperform Candidate With 10.29% Upside Potential

Malibu Boats, Inc. is maintained at an average outperform rating by 7 stock analysts, and there are at least 8.73% of shares outstanding that are currently legally short sold. The shares went down by -2.85% in value last month. Year-to-date it jumped 60.9%. Analysts are turning out to be more optimistic than before, with 6 of analysts who cover Malibu Boats, Inc. (NASDAQ:MBUU) advice adding it to buy candidate list. Wall Street experts also assign a $33.86 price target on Malibu Boats, Inc., pointing towards a 10.29% rally from current levels. The stock is trading for about -7.95% less than its 52-week high.

Malibu Boats, Inc. Reports 28.24% Sales Growth

Malibu Boats, Inc. (MBUU) remained successful in beating the consensus-estimated $0.32 as it actually earned $0.42 per share in its last reported financial results. Revenue, on the other hand, scored 28.24% growth from the previous quarter, coming up with $96.32 million.

MBUU Adds 1.42% In A Week

This company shares (MBUU) so far managed to recover 78.8% since collapsing to its 52-week low. Over a month, it has seen its stock price volatility to stay at 4.61% while shortening the period to a week, volatility was 3.92%. The share price has already crossed its 20 days moving average, floating at a distance of 5.23% and sits 0.12% higher versus its 50 days moving average. When looking at the past five sessions, the stock returned 1.42% gains and is up by 17.53% compared with its 200-day moving average of $27.95. Also, Malibu Boats, Inc. (MBUU) needs to expand a 70.56% increase it experienced over the past twelve months.

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Consensus Call At 2

As regular trading ended, Bio-Path Holdings, Inc. (BPTH) stock brought in a -$0.01 drop to $0.21. The day started at a price of $0.24 but then traded as high as $0.24 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2. Bio-Path Holdings, Inc. is given 0 buy-equivalent recommendations, 0 sells and 0 holds. The company shares sank -84.87% from their peak of $1.38 and now has a $22.49 million market value of equity.

Bio-Path Holdings, Inc. Could Grow 614.29% More

BPTH’s mean recommendation on Reuter’s scale presents no change from 2 thirty days ago to 2 now, which indicates a hold consensus from the analyst community. They see Bio-Path Holdings, Inc. (BPTH) price hitting a mean target of $1.5 a share, meaning the stock still has potential that could lift the price another 614.29% Also, the recent close suggests the stock is underpriced by 614.29% compared to the most bullish target.

Bio-Path Holdings, Inc. (BPTH) Returns -84.57% This Year

The company had seen its current volume reaching at 1.19 million shares in the last trade. That compares with the recent volume average of 0.57 million. At the close of regular trading, its last week’s stock price volatility was 12.09% which for the month reaches 19.17%. Bio-Path Holdings, Inc. dipped to as low as $0.2 throughout the day and has returned -84.57% in this year. At one point in the past year, the shares traded as low as $0.20 but has recovered 3.12% since then.